Polaris Logo - v2.png
Multiple Sclerosis Market Set to Reach USD 33.57 Billion by 2032, Growing at a CAGR of 5.4% | Polaris Market Research (PMR)
August 19, 2024 08:25 ET | Polaris Market Research & Consulting LLP
New York, USA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The multiple sclerosis market was estimated at USD 21.04 billion in 2023. The market valuation is expected to be USD 33.57 billion...
Logo.jpg
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET | DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
FBI LOGO TM.png
Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™
August 24, 2020 07:56 ET | Fortune Business Insights
Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...
FBI LOGO TM.png
Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights™
July 30, 2020 12:00 ET | Fortune Business Insights
Pune, July 30, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High...